11
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Influence of K + Channel Openers on Interferon-γ Dependent Immune Response in Experimental Allergic Neuritis (Ean)

, , &
Pages 233-241 | Received 16 Feb 1994, Published online: 07 Jul 2009
 

Abstract

We examined the influence of the K+ channel opening drugs BRL 38227, pinacidil and diazoxide on cellular immune response and clinical course of experimental allergic neuritis (EAN) actively induced in Lewis rats by bovine peripheral myelin (BPM). T cell functions of EAN lymph node cells were assessed by measurement of proliferation and by counting of interferon-y secreting cells (IFN-γ sc) in response to the specific antigen BPM and the T cell mitogen phytohemagglutinin (PHA). BRL 38227 and diazoxide at concentrations of 10-5M-10-6M and pinacidil at concentrations of 10-5M-10-7M enhanced the proliferative response to both BPM and PHA. The number of IFN-y sc was suppressed by the K+ channel openers in the same concentration range. There was a tendency of stronger suppression of cultures with high numbers of BPM-reactive IFN-y sc than of cultures with low numbers of BPM-reactive IFN-γ sc. The applied K +” channel openers are primarily acting on ATP-sensitivc K + channels, which have not been found in T cells so far. The drugs may, therefore, excert non-selective effects on conventional voltage-and/or Ca + +-dependent channels of T cells.

A first trial with in vivo administration of 2.5 mg/kg x day of the drugs resulted in more severe neurological deficits in the early phase of EAN with BRL 38227, whereas pinacidil and diazoxide had no significant effects.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.